TO DEVELOP A THERAPEUTIC SMALL MOLECULE VIRAL ENTRY INHIBITOR AS A MEDICAL COUNTERMEASURE FOR FILOVIRUS INFECTION.

DEFINITIVE CONTRACT won by ARISAN THERAPEUTICS INC · work in CARLSBAD, CA
$2,933,547
RecipientARISAN THERAPEUTICS INC UEI PYRKTQPNVJZ8
Award ID75N93026C00012
Award amount$2,933,547
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Health and Human Services — National Institutes of Health
NAICS541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSCAN12
Set-asideUnrestricted
Start dateAug 3, 2026
End dateJun 30, 2027
Place of performanceCARLSBAD, CA
Record updatedJul 29, 2026

View the official award record

More awards won by ARISAN THERAPEUTICS INC

TO CONDUCT NON-CLINICAL GOOD LABORATORY PRACTICE (GLP) IN VIVO GENOTOXICITY AND REPRODUCTIVE TOXICOLOGY AND GLP DEVELOPMENT AND REPRODUCTIVE (DART) TOXICOLOGY STUDIES.
Department of Health and Human Services · $3,692,037 · Sep 22, 2023
PHASE II - SBIR TOPIC CBD192-006
Department of Defense · $1,099,662 · Sep 30, 2021
PHASE II BASE PERIOD
Department of Defense · $526,794 · Sep 28, 2021

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids